[Polyene antibiotics and corticosteroids. Experiments with hamycin].

[In vitro studies on the usefulness of 1-p-chlorobenzyl-2-methylbenzimidazole in the treatment of mycoses]. Arch Dermatol Forsch (1971) 0.75

Mechanism of protection by sterols against polyene antibiotics. J Bacteriol (1960) 2.97

EFFECT OF CHOLESTEROL ON THE SENSITIVITY OF MYCOPLASMA LAIDLAWII TO THE POLYENE ANTIBIOTIC FILIPIN. J Bacteriol (1965) 2.40

The action of polyene antibiotics on phospholipid-cholesterol structures. J Biol Chem (1967) 1.67

[The influence of corticosteroids on metabolism of yeasts]. Arch Klin Exp Dermatol (1970) 1.23

Interaction of polyene antibiotics with subcellular membrane systems. I. Mitochondria. Mol Pharmacol (1965) 1.00

HAMYCIN--A NEW ANTIFUNGAL ANTIBIOTIC. Arch Dermatol (1963) 0.89

[Inhibitory effect of local antipsoriatic agents on respiration of human and animal skin]. Arch Klin Exp Dermatol (1969) 1.38

[Bacterial metabolism and corticosteroids]. Arch Klin Exp Dermatol (1969) 1.38

[Antimycotic substances and corticosteroids]. Arch Klin Exp Dermatol (1968) 1.30

[The influence of corticosteroids on metabolism of yeasts]. Arch Klin Exp Dermatol (1970) 1.23

Antibacterial Action of Phenanthrene-related Substances. Science (1946) 1.22

Emotional and sensory stress factors in myocardial pathology. Neurogenic and hormonal mechanisms in pathogenesis, therapy, and prevention. Am Heart J (1966) 1.16

[The effect of external antipsoriatic drugs on the cell respiration]. Arch Klin Exp Dermatol (1966) 1.16

Taking immunogenicity assessment of therapeutic proteins to the next level. Biologicals (2011) 1.12

[Effect of long-wave ultraviolet light (UV-A) and medium-wave ultraviolet rays (UV-B) on human skin. Critical comparison]. Z Hautkr (1980) 1.07

Multiprocessor and memory architecture of the neurocomputer SYNAPSE-1. Int J Neural Syst (1993) 1.07

Influence of age and rumen development on intestinal absorption of galactose and glucose in lambs. A functional and morphological study. Zentralbl Veterinarmed A (1979) 0.99

[Interactions between parabens and dermatologically important antifungal drugs (author's transl)]. Mykosen (1980) 0.98

[Metabolism of corticosteroids in B. pyocyaneus]. Arch Klin Exp Dermatol (1969) 0.90

[Change in the enzyme activity of urine during changes in water and ion excretion]. Clin Chim Acta (1970) 0.90

[Renal enzyme excretion in rats following high doses of penicillin, kanamycin and sulfonamides]. Clin Chim Acta (1968) 0.89

[Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)]. Arch Dermatol Forsch (1974) 0.89

In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity. Arch Dermatol Res (1975) 0.87

[Further development of the International Pneumoconiosis Classification--from ILO 1980 to ILO 2000 and to ILO 2000/German Federal Republic version]. Pneumologie (2003) 0.87

[The effect of steroids (corticosteroids) on the cell respiration inhibiting activity of external antipsoric agents (duthranol and 6-hydroxy-2-ketobenzoxathiol)]. Naturwissenschaften (1966) 0.87

Activation of phosphonomycin, a new antibacterial antibiotic. Pathol Microbiol (Basel) (1971) 0.86

[Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)]. Arch Dermatol Forsch (1974) 0.86

[Age-related heart function in patients with healthy hearts]. Z Kardiol (1988) 0.84

Myocardial electrolyte derangement: crucial feature of pluricausal, so-called coronary, heart disease (dysionic cardiopathy). Ann N Y Acad Sci (1969) 0.84

Myocardial metabolic vulnerability key problem in pluricausal, 'coronary' heart disease. Cardiologia (1968) 0.84

Antibacterial Action of Inactivated Ergosterol in the Guinea Pig and Man. Science (1947) 0.82

Additional studies on the distribution of stresses during vertical compaction of gutta-percha in the root canal. Br Dent J (1999) 0.82

[Collagen metabolism and corticosteroids]. Wien Klin Wochenschr (1967) 0.81

[Specific and unspecific immune stimulation in recurrent herpes simplex]. Z Hautkr (1977) 0.81

[Adhesion of root canal sealers with and without smear layer]. Dtsch Zahnarztl Z (1987) 0.81

[Biochemical-pharmacological observations on the external administration of glucocorticoids alone or together with antimicrobial substances]. Hautarzt (1971) 0.81

[The bactericidal and bacteriostatic effect of gentamicin in the presence of corticosteroids]. Arch Klin Exp Dermatol (1968) 0.81

Training, physical inactivity and the cardiac dynamic cycle (preventive aspects). J Sports Med Phys Fitness (1966) 0.81

Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res (2002) 0.80

[Antipsoriatic effect of dithranol (anthralin). 1]. Hautarzt (1975) 0.80

Adaptation to high-fat diet and carbohydrate-induced satiety in the rat. Am J Physiol (1979) 0.80

Correlated cardiovascular adrenergic and adrenocortical responses to sensory and mental annoyances in man. A potential accessory cardiac risk factor. Psychosom Med (1969) 0.79

[Serum enzyme activities in experimental porphyria in rats]. Arzneimittelforschung (1967) 0.79

[Determination of the leucine aminopeptidase of rat urine using L-leucyl-beta-naphthylamine and L-leucyl-0-nitroanilide]. Z Klin Chem Klin Biochem (1966) 0.79

Hohenheimer Consensus Talk. Oxidative and premature skin ageing. Exp Dermatol (2003) 0.79

[Adverse side effects of amalgam? An interdisciplinary study]. Dtsch Zahnarztl Z (1991) 0.78

[Experimental studies on hydroxyproline excretion following burns]. Arch Klin Exp Dermatol (1966) 0.78

[The effectiveness of fungistatic antibiotic agents in the presence of neomycin and corticosteroids]. Arch Klin Exp Dermatol (1967) 0.78

[Acute side effects of erythromycin, lincomycin and clindamycin]. Int J Clin Pharmacol Biopharm (1977) 0.78

Collagenolytic activity of snake and spider venoms. Toxicon (1967) 0.78

[Interactions between amphotericin B and hydroxytetracycline]. Z Hautkr (1980) 0.77

[Recommendations for reporting benign asbestos-related findings in chest X-ray and CT to the accident insurances]. Pneumologie (2009) 0.77

D-penicillamine in dermatology: influence on enzymatic activities of human skin in vitro. Arch Dermatol Res (1975) 0.77

[Dental prophylaxis and treatment in patients with radiation injuries]. MMW Munch Med Wochenschr (1982) 0.77

Inhibition of alkaline phosphatase activity by D-penicillamine. Z Klin Chem Klin Biochem (1974) 0.77

[Experimental studies on appearance of kidney changes following D-penicillamine]. Int J Clin Pharmacol (1974) 0.77

Isolation, stress, myocardial electrolytes, and epinephrine cardiotoxicity in rats. Proc Soc Exp Biol Med (1968) 0.77

[Inhibition of cytotoxic activity through heparin]. Wien Klin Wochenschr (1967) 0.77

[Examples for asbestos-related findings in HRCT - criteria for the assessment of causal relationships in surveillance programmes and medical expert opinion]. Pneumologie (2009) 0.77

[The action of D-penicillamine (dimethylcysteine) on human dermal proteins; a comparison with acetylcysteine (author's transl)]. Arch Dermatol Forsch (1974) 0.77

[The effect of heparin on the anthus phenomenon]. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.77

Renal effects of gentamicin and cephaloridine. Evaluation by renal enzyme excretion studies in rats and comparison with other antibiotics. Arzneimittelforschung (1976) 0.77

[CT study and standardised findings in occupationally-induced changes in the lungs and pleura with reference to the ILO 1980 classification of dust-induced pneumoconiosis]. Rontgenpraxis (1994) 0.76

[Effects of ultraviolet light on human dermal collagen in vitro]. Arch Klin Exp Dermatol (1969) 0.76

[Effect of D-penicillamine on the metabolism of bacteria and yeasts]. Mykosen (1972) 0.76

Reciprocal relationship between Rumen development and intestinal sugar transport capacity in sheep. Zentralbl Veterinarmed A (1979) 0.76

Nephrotoxic action of D-serine determined by renal enzyme excretion in rats. Pharmacology (1969) 0.76

[Effectiveness of combined antibacterial chemotherapy--in vitro studies]. Arch Klin Exp Dermatol (1970) 0.75

Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods. Arch Dermatol Res (1977) 0.75

[On the histamine liberating effect of neomycin: the reactivity of neomycin with heparin]. Arch Klin Exp Dermatol (1967) 0.75

[In vitro studies on the usefulness of 1-p-chlorobenzyl-2-methylbenzimidazole in the treatment of mycoses]. Arch Dermatol Forsch (1971) 0.75

2-Nitro-2-bromopropan-1,3-diol (bronopol) and UV-rays. Arch Dermatol Res (1980) 0.75

The inhibition of glucose-6-phosphate dehydrogenase activity by dithranol (anthralin), zinc ions and/or salicylic acid. Arch Dermatol Forsch (1974) 0.75

Pre-necrotic epinephrine and corticoid-induced myocardial electrolyte shifts. Histochemical and chemical studies. Cardiologia (1968) 0.75

[Topical use of phosphonomycin]. Arch Dermatol Forsch (1973) 0.75

The effects of analgesics on pain-related somatosensory evoked potentials. Agents Actions Suppl (1986) 0.75

Urinary 3-Methoxy-4-hydroxymandelic acid (VMA) in ischemic heart disease and in uremia. Am J Med Sci (1965) 0.75

Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid. Experientia (1968) 0.75

[The immunological importance of microbial organisms on the skin surfaces]. Allerg Asthma (Leipz) (1969) 0.75

[False diagnosis in drug allergies due to anaphylactoid reactions]. Allerg Asthma (Leipz) (1967) 0.75

[Changes of amino acids and transaminases in the liver and in serum of rats during potassium deficiency]. Wien Klin Wochenschr (1969) 0.75

[Enzyme activation as result of antigen-antibody reactions]. Allerg Asthma (Leipz) (1966) 0.75

[Variations of collagen metabolism in bone tuberculosis]. Z Orthop Ihre Grenzgeb (1968) 0.75

[Model experiments in vitro for the proof of anaphylactoid effects]. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.75

[Urinary hydroxyproline excretion in generalized bone diseases]. Wien Z Inn Med (1967) 0.75

[Dermatological aspects of drug allergies in the USA]. Allerg Asthma (Leipz) (1967) 0.75

[The modification of allergic reactions through pretreatment with anaphylactoid substances]. Wien Klin Wochenschr (1966) 0.75

Pathophysiological fundamentals of the origin and prevention of degenerative heart disease. Ann N Y Acad Sci (1969) 0.75

[Analgetics and renal enzyme excretion: urine enzyme activities in rats following administration of high doses of autylsalicylic acid]. Clin Chim Acta (1968) 0.75

Prevention of "ischemic" (so-called "coronary") heart disease. Mich Med (1965) 0.75

Pluricausal pathogenesis and preventability of ischemic heart disease. Dis Chest (1968) 0.75

Commentaries. Can Med Assoc J (1967) 0.75

[Experimental studies on the changes in leucine aminopeptidase activity of the urine]. Wien Klin Wochenschr (1966) 0.75

Origin and prevention of so-called "coronary" heart disease. J Tenn Med Assoc (1966) 0.75

[Prophylaxis of allergic reactions by inhibition of histidine decarboxylase]. Ther Ggw (1970) 0.75

[Acid phosphatase activity in the rat urine]. Klin Wochenschr (1966) 0.75

[Effect of the sympathetic and adrenal system on cardiovascular circulatory regulation and unesterified fatty acids on the blood serum]. Dtsch Med Wochenschr (1966) 0.75